ESMO - European Society for Medical Oncology

📣 All accepted Proffered Paper, Mini Oral, Poster and ePoster abstracts for #ESMORareCancers26 are now online!
Dive into the latest research advancing sarcoma and rare cancers care.

🔗 https://ow.ly/GQI450Yp3SR

#esmomeetings

@lizzysmyth.bsky.social @ptarantinomd.bsky.social @erikahamilton9.bsky.social @drjonlim.bsky.social @omalirp.bsky.social @alfdoc2.bsky.social @jiajennyliu.bsky.social @yukselurun.bsky.social
@aftimosp.bsky.social @guinadermarta.bsky.social @herbloongmd.bsky.social @dramartinezlago.bsky.social

Do you have an impactful research idea?
One that could improve care or advance science?

Apply for the ESMO Leadership & Career Development Award, offering protected research time, leadership & communication training by 3 May 26 .

🔗https://ow.ly/Gicm50YqcbZ

#Oncology #ESMOYOC

📣 #ESMO26: The registration system is now open!
Join us at an event where multidisciplinary innovation meets global collaboration.
⏰ Big savings if you register before 22 July 2026

🔗 https://ow.ly/lg7S50YoACx

#esmomeetings

👉 Prof. Pierre Laurent‑Puig, ESMO GI 2026 Scientific Committee member, invites all experts in GI cancers to bring their science to the meeting that matters.

📍 Munich & online | 🗓 1–4 July 2026
📝 Submit your abstract now!
https://ow.ly/iKKs50YnSzf

#ESMOGI26 #esmomeetings

@dyrskjot.bsky.social @niklaskluemper.bsky.social

🌐Join this #ESMODeepDive to refine treatment sequencing, manage variant histologies, and apply biomarker‑driven care.
Live Q&A 💬 ESMO member: register to secure your seat:
🔗 https://ow.ly/E5qk50YoqoX

Live viewers earn 2 ESMO‑MORA Category 1 points
#ESMOWebinar #ESMOOnAir

⏳ Early fee ends 28 Apr.

📝 #ESMOExamination 2026 is on 24 Oct (13:00–15:30 CEST) — main session onsite in Madrid + parallel sessions in selected locations.
🔗 Secure your seat: https://ow.ly/Rxub50YnZiW

📣 #ESMO26: Global collaboration starts here. Submit your abstract and engage with the full spectrum of innovation—from basic science to clinical development. Deadline 12 May 2026

🔗 https://ow.ly/IfQE50YmOWt

#esmomeetings

YouTube Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

📹 Another inspiring Diary of an Oncology Leader episode is here: Erika Ruiz shares insights on how #empathy and #adaptability shape #ProfessionalGrowth. Jarushka Naidoo
🔗 https://ow.ly/witW50YlJRn
#ESMOW4O #W4O

📣 ESMO Oncogene-addicted mNSCLC Living Guideline v1.3 update: New algorithms and recommendations for c-Met overexpression, NRG1 gene fusion, EGFR mutations and HER2 alterations.

🔗 https://ow.ly/82yx50YmhtR

#ClinicalPracticeGuideline

Why are older adults still not properly considered in #ClinicalResearch? In the #ESMODailyReporter, Anna Mislang & Capucine Baldini highlight key barriers and stress the need to integrate #QoL, functional independence and patient priorities in trial design.
➡️ https://ow.ly/vG6J50YmlfO

📣 #ESMOBreast26: Get inspired and be part of the conversation shaping the future of breast cancer treatment and care. Last chance to register and save!
⏰ Deadline 26 February 2026

🔗 https://ow.ly/8RGA50YlJQm

#esmomeetings

The next #ESMOGuidelines webinar focuses on #GastroesophagealCancer — from biomarker testing to immunotherapy integration.
🎙 Live Q&A with expert faculty
🎓 Earn 1 ESMO-MORA Cat. 1 point
🆓 Open to all with an ESMO account

🔗 Join us: https://ow.ly/SU2g50YlJnP

#ESMOOnAir #ESMOWebinars

Unlocking unstructured #EMR data is key to understanding cancer trajectories.
A study in ESMO Real World Data & Digital Oncology shows how #NLP can extract #ClinicalInsights from narrative clinical documentation.
Read Rodrigo Dienstmann in the #ESMODailyReporter
➡️ https://ow.ly/LC2o50YkRYS

📣 #ELCC26: innovation meets collaboration.

🎥 Hear López‑Ríos on key trends (earlier biomarkers, AI, predictive biomarkers for ADCs) and Leighl on the value of networking & data‑sharing at ELCC.

🔗 Preferential rates end 25 Feb: https://ow.ly/7nlg50YkTgS

#esmomeetings

#ICHNO26 🔔 Late registration closes tomorrow! Register by 25 Feb
🔗 https://ow.ly/2B4j50YkRvi

Get randomised trial updates, expert debate and practical takeaways — plus multidisciplinary exchange.
📍 Seville | 19–21 Mar 2026

#HeadAndNeckOncology #esmomeetings

@siogorg.bsky.social

ESMO and SIOG publish a joint paper on improving clinical trial designs for #OlderAdults with cancer. Key points: include older adults, engage patients/caregivers, use adaptive designs & integrate geriatric assessment.
Read the full paper: https://ow.ly/8QGn50Yk5jP
#GeriOnc

➡️ New ESMO Living Guideline on Local and Locoregional Prostate Cancer. Consult all recommendations & algorithms from the recent #ClinicalPracticeGuideline in an interactive format, also mobile friendly.
🔗 https://ow.ly/zi8P50YhZy5

📣 #ESMOBreast26: The place to gain exclusive insights into the latest advancements in breast cancer treatment and care.
⏰ Last days to benefit from big savings! Deadline 26 February 2026

🔗 https://ow.ly/bvt450YccxW
#esmomeetings

Prof. Florian Lordick, ESMO GI 2026 Scientific Committee member, invites you to Munich — onsite or online — for a key GI oncology meeting of the year.

🗓️ 1–4 July 2026
⏰ Early reg: 15 April
👉 Register now: https://ow.ly/FtGR50YcGIt

#ESMOGI26 #esmomeetings

👉 Stay ahead of emerging #toxicity challenges in next‑gen #immunotherapies. Get insights from experts and join the live Q&A.

🔗 Register now and earn 1 ESMO-MORA point: https://ow.ly/HMns50YcO6k

#ESMOOnAir #ESMOWebinars

👉 Prof. David Thomas, Sydney, Australia, ESMO Sarcoma and Rare Cancers 2026 Scientific Co-Chair, invites you to join a gathering where rare cancers research comes together to drive real-world impact. Register now!
🔗 https://ow.ly/PCAR50Yclm5
#ESMORareCancers26 #esmomeetings

🎥 Hear Jarushka Naidoo on why #ELCC26 is an intimate meeting where young oncologists meet experts, ask questions & build mentorships.

⏳ Late registration ends 25 Feb. Secure your seat (onsite in Copenhagen & online): 🔗 https://ow.ly/GMof50YcHbj

#LungCancer #esmomeetings

#ICHNO26 🔔 Late registration is still open!
Register by 25 Feb
🔗 https://ow.ly/ALal50YbKWf
Strengthen clinical decision-making with cutting-edge science, randomised trial updates & multidisciplinary expert exchange

📍 Seville | 19–21 March 2026

#HeadAndNeckOncology #esmomeetings

📣#ESMOGynae26: From breakthroughs in ovarian cancer therapies to new hope for rare tumours, every session is designed to bring us closer to better outcomes, earlier diagnoses, and more personalised care
⏰Share your research by 31 March 2026
#esmomeetings
🔗 https://ow.ly/MhOS50Y9XcE

📣ESMO #ClinicalPracticeGuideline on #Lymphomas - New Living Guideline recommendations in the relapsed/refractory setting:
- Epcoritamab combinations and odronextamab in Follicular Lymphoma
- Sonrotoclax in Mantle Cell Lymphoma thrid-line or later

🔗 https://ow.ly/v7Uo50YcbSE

📣 #ESMO26: Secure your stay and join us in Madrid, Spain, from 23 to 27 October 2026.
#esmomeetings

🔗 https://ow.ly/LPq250Y9Trc

📣Updated ESMO #ClinicalPracticeGuideline on advanced and metastatic #ProstateCancer:
✅ Substantial advances in castration-sensitive & -resistant prostate cancer
✅ Updated algorithms & recommendations reflecting latest clinical data
#ESMOGuidelines Christopher Sweeney

🔗 https://ow.ly/E4ov50Yc8e2